Skip to content

Multicenter Quantitative and Qualitative Study of the Determinants of Participation in a Cytomegalovirus Preventive Vaccine Study in France in Women Aged 18 to 40 Years Old.

Multicenter Quantitative and Qualitative Study of the Determinants of Participation in a Cytomegalovirus Preventive Vaccine Study in France in Women Aged 18 to 40 Years Old.

Status
Not yet recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06511635
Enrollment
306
Registered
2024-07-22
Start date
2024-09-30
Completion date
2024-11-30
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Recruitment

Keywords

Recruitment methods, Determinants, CMVCTORY vaccine trial, women's participation, vaccine trial

Brief summary

During a vaccine clinical trial of Cytomegalovirus (CMV) vaccine, one of the participants' motivations was to prevent an infection responsible for malformations in a future child. Would their attitude towards a vaccine trial be the same in the context of a vaccine designed to protect them individually? By improving the knowledge of clinical research and determinants in women aged 18 to 40, this study could improve recruitment methods in this specific population for future vaccine trials within the CIC1408 infectious diseases and vaccinology area at Saint-Etienne University Hospital.

Interventions

OTHERQualitative interview

Interview between participant and a researcher, in order to identity the determinants of participation in a clinical trial among participants in the CMVictory vaccine trial.

OTHERQuantitative questionnaire

Anonymous online survey using a 3-part questionnaire, studying knowledge of clinical research and the determinants of participation in a preventive vaccine study in a population of young women (aged 18-40).

Sponsors

Centre Hospitalier Universitaire de Saint Etienne
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
RETROSPECTIVE

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 40 Years
Healthy volunteers
Yes

Inclusion criteria

* Womens between 18 to 40 included in CMVCTORY vaccine trial

Exclusion criteria

* Refusal

Design outcomes

Primary

MeasureTime frameDescription
qualitative interviewDay : 1To identify the motivations and the obstacles of participation in an experimental trial in women of childbearing age in Phase 3 trial.

Countries

France

Contacts

Primary ContactNelly JACQUEMET, nurse
rechercheclinique.infectiologie.IDE@chu-st-etienne.fr(0)477829658

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026